NZ184114A - Benzo (c) qyinoline derivatives and pharmaceutical compositions - Google Patents
Benzo (c) qyinoline derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ184114A NZ184114A NZ184114A NZ18411477A NZ184114A NZ 184114 A NZ184114 A NZ 184114A NZ 184114 A NZ184114 A NZ 184114A NZ 18411477 A NZ18411477 A NZ 18411477A NZ 184114 A NZ184114 A NZ 184114A
- Authority
- NZ
- New Zealand
- Prior art keywords
- qyinoline
- benzo
- derivatives
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
- 125000005605 benzo group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
- C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5456—Arylalkanephosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68733276A | 1976-05-17 | 1976-05-17 | |
| US75361976A | 1976-12-22 | 1976-12-22 | |
| US77792877A | 1977-03-15 | 1977-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ184114A true NZ184114A (en) | 1982-02-23 |
Family
ID=27418484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ184114A NZ184114A (en) | 1976-05-17 | 1977-05-16 | Benzo (c) qyinoline derivatives and pharmaceutical compositions |
Country Status (23)
| Country | Link |
|---|---|
| JP (1) | JPS6016426B2 (enExample) |
| AR (1) | AR215896A1 (enExample) |
| BG (4) | BG27897A3 (enExample) |
| CA (1) | CA1095909A (enExample) |
| CH (2) | CH626881A5 (enExample) |
| DD (1) | DD130855A5 (enExample) |
| DE (1) | DE2722383A1 (enExample) |
| DK (1) | DK212677A (enExample) |
| ES (4) | ES458812A1 (enExample) |
| FI (1) | FI64141C (enExample) |
| FR (2) | FR2362129A1 (enExample) |
| GR (1) | GR74122B (enExample) |
| IL (1) | IL52087A (enExample) |
| LU (1) | LU77341A1 (enExample) |
| NL (2) | NL170141C (enExample) |
| NO (1) | NO147028C (enExample) |
| NZ (1) | NZ184114A (enExample) |
| PH (1) | PH16833A (enExample) |
| PT (1) | PT66550B (enExample) |
| RO (1) | RO76839A (enExample) |
| SE (1) | SE7704749L (enExample) |
| SU (1) | SU1098520A3 (enExample) |
| YU (2) | YU156982A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2802211A1 (de) * | 1978-01-19 | 1979-07-26 | Basf Ag | N-substituierte 2,6-dialkylaniline und verfahren zur herstellung von n- substituierten 2,6-dialkylanilinen |
| US4206225A (en) * | 1978-09-22 | 1980-06-03 | Pfizer Inc. | 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines |
| US4228169A (en) * | 1979-06-26 | 1980-10-14 | Pfizer Inc. | 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents |
| US4309545A (en) * | 1980-07-28 | 1982-01-05 | Pfizer Inc. | Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof |
| US4406888A (en) * | 1981-01-09 | 1983-09-27 | Pfizer Inc. | Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution |
| HU194858B (en) * | 1982-12-03 | 1988-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them |
| CN105924386A (zh) * | 2009-03-25 | 2016-09-07 | Abbvie 公司 | 抗病毒化合物和其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636058A (en) * | 1966-03-25 | 1972-01-18 | Hoffmann La Roche | 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones |
| US3507885A (en) * | 1966-03-25 | 1970-04-21 | Hoffmann La Roche | 3-alkyl-6h-dibenzo(b,d)pyrans |
| US3649650A (en) * | 1970-02-13 | 1972-03-14 | Little Inc A | Novel derivatives of tetrahydro-cannabinol |
| CA994791A (en) * | 1971-05-12 | 1976-08-10 | Louis S. Harris | Esters of benzopyrans |
| US3856821A (en) * | 1973-07-18 | 1974-12-24 | Smithkline Corp | ALKOXY DIBENZO (b,d) PYRANS |
| US3968125A (en) * | 1973-11-05 | 1976-07-06 | Eli Lilly And Company | Dihydroxyhexahydrodibenzo[b,d]pyrans |
| US3928598A (en) * | 1973-11-05 | 1975-12-23 | Lilly Co Eli | Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug |
| US3944673A (en) * | 1973-11-05 | 1976-03-16 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs |
| GB1522057A (en) * | 1975-11-03 | 1978-08-23 | Pfizer | 9-hydroxydibenzo(b,d)pyrans and intermediates therefor |
-
1977
- 1977-04-25 SE SE7704749A patent/SE7704749L/xx not_active Application Discontinuation
- 1977-05-13 DE DE19772722383 patent/DE2722383A1/de active Granted
- 1977-05-13 CA CA278,410A patent/CA1095909A/en not_active Expired
- 1977-05-13 DD DD7700198919A patent/DD130855A5/xx unknown
- 1977-05-13 IL IL52087A patent/IL52087A/xx unknown
- 1977-05-13 PH PH19772A patent/PH16833A/en unknown
- 1977-05-14 ES ES458812A patent/ES458812A1/es not_active Expired
- 1977-05-16 NO NO771738A patent/NO147028C/no unknown
- 1977-05-16 CH CH610477A patent/CH626881A5/fr not_active IP Right Cessation
- 1977-05-16 PT PT66550A patent/PT66550B/pt unknown
- 1977-05-16 NZ NZ184114A patent/NZ184114A/xx unknown
- 1977-05-16 FI FI771550A patent/FI64141C/fi not_active IP Right Cessation
- 1977-05-16 DK DK212677A patent/DK212677A/da not_active Application Discontinuation
- 1977-05-16 LU LU77341A patent/LU77341A1/xx unknown
- 1977-05-16 GR GR53474A patent/GR74122B/el unknown
- 1977-05-17 BG BG036340A patent/BG27897A3/xx unknown
- 1977-05-17 NL NLAANVRAGE7705433,A patent/NL170141C/xx active
- 1977-05-17 BG BG037711A patent/BG28414A4/xx unknown
- 1977-05-17 RO RO7796757A patent/RO76839A/ro unknown
- 1977-05-17 BG BG037713A patent/BG28416A4/xx unknown
- 1977-05-17 JP JP52056068A patent/JPS6016426B2/ja not_active Expired
- 1977-05-17 BG BG037712A patent/BG28415A4/xx unknown
- 1977-05-17 AR AR267660A patent/AR215896A1/es active
- 1977-05-17 FR FR7715049A patent/FR2362129A1/fr active Granted
-
1978
- 1978-04-26 NL NL7804461A patent/NL7804461A/xx not_active Application Discontinuation
- 1978-04-27 ES ES469202A patent/ES469202A1/es not_active Expired
- 1978-04-27 ES ES469203A patent/ES469203A1/es not_active Expired
- 1978-04-27 ES ES469204A patent/ES469204A1/es not_active Expired
-
1980
- 1980-02-14 FR FR8003318A patent/FR2446284A1/fr active Granted
- 1980-08-18 CH CH621980A patent/CH628034A5/fr not_active IP Right Cessation
-
1981
- 1981-03-05 SU SU813254395A patent/SU1098520A3/ru active
-
1982
- 1982-07-19 YU YU01569/82A patent/YU156982A/xx unknown
- 1982-07-19 YU YU01568/82A patent/YU156882A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ180529A (en) | Erythromyc-9-yl-amine derivatives and pharmaceutical compositions | |
| NZ183150A (en) | 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions | |
| NZ187235A (en) | Aminoalkylbenzene derivatives and pharmaceutical compositions | |
| NZ185105A (en) | Thiazolidine derivatives and pharmaceutical compositions | |
| NZ188974A (en) | 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions | |
| NZ184281A (en) | Hydantoin derivatives and pharmaceutical compositions | |
| DE2862107D1 (en) | Glucosamine-peptide derivatives and their pharmaceutical compositions | |
| NZ184755A (en) | 2-benzylpyrrolidine derivatives and pharmaceutical compositions | |
| NZ188772A (en) | Pyrazinobenzoxazepine derivatives and pharmaceutical compositions | |
| NZ185642A (en) | Morphanthridine derivatives and pharmaceutical compositions | |
| NZ188038A (en) | Di-orthosubstituted benzene derivatives and pharmaceutical compositions | |
| NZ184981A (en) | Thiophene derivatives and pharmaceutical compositions containing them | |
| NZ188798A (en) | 2-iminoimidazolidine derivatives and pharmaceutical compositions | |
| NZ184103A (en) | Fenzodioxole derivatives and pharmaceutical compositions | |
| NZ182161A (en) | Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions | |
| NZ184102A (en) | Derivatives of benzenesulphonylurea,and pharmaceutical compositions | |
| NZ187085A (en) | 3-pyridazione derivatives and pharmaceutical compositions | |
| NZ187571A (en) | N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions | |
| NZ187164A (en) | N-phenyl-m-(j-piperidinyl)-amide derivatives and pharmaceutical compositions | |
| IL52087A (en) | Benzo(c)quinoline derivatives and pharmaceutical compositions containing them | |
| PH12641A (en) | Benzodiazepines derivatives and pharmaceutical compositions thereof | |
| NZ181727A (en) | Pyrroline-2-one derivatives and pharmaceutical compositions | |
| NZ187195A (en) | Benzenesulphonyl-urea derivatives and pharmaceutical compositions | |
| NZ185267A (en) | Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them | |
| NZ181401A (en) | 2-benzopyranone derivatives and pharmaceutical compositions |